Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27732716 | 0.98 | TSHR (0.67) | TSHRLMNATDP1KMT2AMAPK1 | |
| Hydrochloric Acid SCHEMBL28478926 | 0.98 | TSHR (0.67) | TSHRLMNATDP1KMT2AMAPK1 | |
| SCHEMBL16248436 | 0.94 | TSHR (0.62) | TSHRLMNATDP1KMT2AMAPK1 | |
| SCHEMBL17932907 | 0.94 | TSHR (0.62) | TSHRLMNATDP1KMT2AMAPK1 | |
| SCHEMBL1372828 | 0.94 | TSHR (0.62) | TSHRLMNATDP1KMT2AMAPK1 | |
| Hydrochloric Acid SCHEMBL28152832 | 0.93 | TSHR (0.61) | TSHRLMNATDP1KMT2AMAPK1 | |
| Propene SCHEMBL14059331 | 0.91 | TSHR (0.59) | TSHRLMNATDP1KMT2AMAPK1 | |
| Propene SCHEMBL2507960 | 0.91 | TSHR (0.59) | TSHRLMNATDP1KMT2AMAPK1 | |
| SCHEMBL9969969 | 0.90 | TSHR (0.64) | TSHRLMNATDP1MAPK1SLC6A2 | |
| SCHEMBL137486 | 0.89 | TDP1 (0.83) | TSHRLMNATDP1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12365785-B2 | Glycol ether aryl ester plasticizer | EASTMAN CHEMICAL COMPANY (US) | 2025-07-22 | — | — | US | claimed |
| CN-117929549-A | Method for detecting two genotoxic impurities and application thereof | 北京海美源医药科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-113493443-B | Application of erlotinib derivative in preparation of medicines for treating esophageal cancer | 侯延生 | 2023-06-27 | — | — | CN | claimed |
| CN-115926331-A | Polybutene-1 alloy and preparation method thereof | 中国石油天然气股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| US-20220227962-A1 | GLYCOL ETHER ARYL ESTER PLASTICIZER | EASTMAN CHEMICAL COMPANY (US) | 2022-07-21 | — | — | US | claimed |
| EP-3990532-A1 | GLYCOL ETHER ARYL ESTER PLASTICIZER | Eastman Chemical Company (US) | 2022-05-04 | — | — | EP | claimed |
| CN-114008119-A | Glycol ether aryl ester plasticizers | 伊士曼化工公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113493443-A | Erlotinib derivative with killing performance on wild lung cancer tumor cells and preparation method thereof | 侯延生 | 2021-10-12 | — | — | CN | claimed |
| CN-106916067-B | Preparation method of erlotinib hydrochloride key intermediate | 江苏豪森药业集团有限公司 | 2021-07-06 | — | — | CN | claimed |
| CN-108341902-B | Catalyst component for ethylene polymerization, preparation method thereof and catalyst for ethylene polymerization | 中国石油化工股份有限公司 | 2021-07-02 | — | — | CN | claimed |
| US-20120157295-A1 | Process for Producing Procatalyst Composition with Alkoxyalkyl Ester Internal Electron Donor and Product | W. R. GRACE & CO. - CONN. | 2012-06-21 | — | — | US | claimed |
| US-20090321646-A1 | NON-DESTRUCTIVE ANALYSIS BY VIS-NIR SPECTROSCOPY OF FLUID(S) IN ITS ORIGINAL CONTAINER | THE AUSTRALIAN WINE RESEARCH INSTITUTE (AU) | 2009-12-31 | — | — | US | claimed |
| EP-1904828-A4 | NON-DESTRUCTIVE ANALYSIS BY VIS-NIR SPECTROSCOPY OF FLUID (S) IN ITS ORIGINAL CONTAINER | AUSTRALIAN WINE RES INST (AU) | 2008-11-19 | — | — | EP | claimed |
| EP-1904828-A1 | NON-DESTRUCTIVE ANALYSIS BY VIS-NIR SPECTROSCOPY OF FLUID (S) IN ITS ORIGINAL CONTAINER | The Australian Wine Research Institute (AU) | 2008-04-02 | — | — | EP | claimed |
| WO-2007006099-A1 | NON-DESTRUCTIVE ANALYSIS BY VIS-NIR SPECTROSCOPY OF FLUID (S) IN ITS ORIGINAL CONTAINER | THE AUSTRALIAN WINE RESEARCH INSTITUTE (AU) | 2007-01-18 | — | — | WO | claimed |
| WO-2002033404-A2 | INTEGRATED WINE QUALITY SENSOR | TRAUNER KENNETH B (US) | 2002-04-25 | — | — | WO | claimed |
| EP-0247737-B1 | THERMAL TRANSFER PRINTING | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-08-08 | — | — | EP | claimed |
| US-4808568-A | AZOPYRIDONE YELLOW DYE COATING ON SHEET; BRIGHTNESS, LIGHTFASTNESS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-02-28 | — | — | US | claimed |
| EP-0247737-A1 | Thermal transfer printing | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-12-02 | — | — | EP | claimed |
| US-4221566-A | POLYAMIDE FIBERS, DISPERSE BLUE 79 | VELSICOL CHEMICAL CORPORATION (US) | 1980-09-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12365785-B2 | Glycol ether aryl ester plasticizer | DAGLA, DDT, PPARG | TSHR 2825/4885LMNA 1384/4885TDP1 1253/4885 |
| US-20220227962-A1 | GLYCOL ETHER ARYL ESTER PLASTICIZER | DAGLA, DDT, PPARG | TSHR 2825/4885LMNA 1384/4885TDP1 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.